Chimerix, Inc. (CMRX) financial statements (2020 and earlier)

Company profile

Business Address 2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC 27713
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments97187152232220235110
Cash and cash equivalents 81195121128110
Short-term investments97105133181200106 
Receivables2022200
Prepaid expense 00001 
Deferred costs      0
Prepaid expense and other current assets3
Other current assets 1111  
Other undisclosed current assets2712252 
Total current assets:126189157236229237113
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment1123310
Long-term investments and receivables  774712453 
Long-term investments  774712453 
Deposits noncurrent assets      0
Deferred costs      0
Other noncurrent assets000000 
Total noncurrent assets:217950127540
TOTAL ASSETS:128191235287356292113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1513131020136
Accounts payable35441062
Accrued liabilities128961072
Employee-related liabilities      2
Debt     46
Other undisclosed current liabilities      (2)
Total current liabilities:15131310201710
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt 000000
Deferred revenue and credits 0   
Other liabilities 00 000
Other undisclosed noncurrent liabilities0     4
Total noncurrent liabilities:0000005
Total liabilities:16131311211715
Stockholders' equity
Stockholders' equity attributable to parent, including:11217822227633527599
Common stock     00
Additional paid in capital777734710692676497261
Accumulated other comprehensive income (loss)0(0)(1)(0)(1)0 
Accumulated deficit(665)(556)(487)(416)(339)(222)(163)
Other undisclosed stockholders' equity attributable to parent00000  
Total stockholders' equity:11217822227633527599
TOTAL LIABILITIES AND EQUITY:128191235287356292113

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net461144
Gross profit:117461144
Operating expenses(138)(79)(77)(84)(129)(63)(41)
Other undisclosed operating income      8
Operating loss:(128)(72)(72)(78)(118)(59)(29)
Interest and debt expense    (0)(0)(1)
Loss before gain (loss) on sale of properties:(128)(72)(72)(78)(118)(59)(30)
Other undisclosed net income (loss)52121(0)(7)
Net loss:(122)(69)(71)(76)(117)(59)(36)
Other undisclosed net loss attributable to parent(2)     (34)
Net loss attributable to parent:(124)(69)(71)(76)(117)(59)(71)
Preferred stock dividends and other adjustments      (1)
Net loss available to common stockholders, diluted:(124)(69)(71)(76)(117)(59)(72)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(122)(69)(71)(76)(117)(59)(36)
Other comprehensive loss    (118)(59)(36)
Comprehensive loss:(122)(69)(71)(76)(236)(119)(73)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)1(1)0   
Comprehensive loss, net of tax, attributable to parent:(123)(69)(72)(76)(236)(119)(73)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: